Pharmacologic activity, safety, and preliminary efficacy of GEN3009, a CD37-targeting DuoHexaBody, in relapsed or refractory B-cell non-Hodgkin’s lymphoma
Farrukh T. Awan, Joshua T. Gamse, Marije B. Overdijk, Esther C W Breij et autres
us, nl, dk, es (code pays fourni par la source)